CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$2,477,507
-68.7%
153,406
-19.7%
0.00%
-71.4%
Q2 2023$7,925,961
-33.1%
190,987
-3.1%
0.01%
-36.4%
Q1 2023$11,850,587
-29.3%
197,050
-13.8%
0.01%
-21.4%
Q4 2022$16,771,698
+5.4%
228,653
+9.2%
0.01%
-6.7%
Q3 2022$15,911,000
+23.3%
209,407
+12.8%
0.02%
+25.0%
Q2 2022$12,908,000
-19.7%
185,721
-4.3%
0.01%0.0%
Q1 2022$16,082,000
-5.8%
194,110
-14.6%
0.01%
+9.1%
Q4 2021$17,073,000
-35.7%
227,395
-0.5%
0.01%
-45.0%
Q3 2021$26,558,000
-48.2%
228,615
-1.2%
0.02%
-47.4%
Q2 2021$51,315,000
+62.3%
231,337
-3.3%
0.04%
+58.3%
Q1 2021$31,627,000
-17.7%
239,271
+7.8%
0.02%
-20.0%
Q4 2020$38,415,000
+65.4%
221,998
+6.4%
0.03%
+42.9%
Q3 2020$23,226,000
+75.5%
208,663
-6.5%
0.02%
+61.5%
Q2 2020$13,235,000
+0.6%
223,180
+14.2%
0.01%
-18.8%
Q1 2020$13,158,000
-33.1%
195,403
-16.2%
0.02%
-11.1%
Q4 2019$19,659,000
+38.7%
233,282
+23.1%
0.02%
+28.6%
Q3 2019$14,176,000
+60.5%
189,572
+35.7%
0.01%
+40.0%
Q2 2019$8,830,000
+30.9%
139,648
-0.3%
0.01%
+25.0%
Q1 2019$6,748,000
+42.2%
140,088
-1.1%
0.01%
+14.3%
Q4 2018$4,744,000
-38.3%
141,688
-3.4%
0.01%
-30.0%
Q3 2018$7,684,000
+260.4%
146,635
+115.3%
0.01%
+233.3%
Q2 2018$2,132,000
+13.6%
68,121
-20.9%
0.00%0.0%
Q1 2018$1,877,00086,1020.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders